
SyntheticGestalt (Shinjuku, Tokyo; CEO Koki Shimada; hereinafter "our company") is pleased to announce that our company will exhibit at the CBI 2025 Annual Meeting, to be held from October 27-30, 2025, and host a session titled "Advances in Foundation Models: Transforming Drug Discovery and Life Sciences." This session will feature speakers from the Institute of Science Tokyo, Preferred Networks, and Alivexis who will discuss the significance and future potential of foundation models.
About session
・Theme: Advances in Foundation Models: Transforming Drug Discovery and Life Sciences
・Date & Time: October 28th, 14:00-15:30
・Location: Room 401, Tower Hall Funabori
・Overview: With advances in AI, foundation models are becoming increasingly important in life sciences, including drug discovery. In this session, four speakers will present the latest case studies from their areas of expertise and discuss the possibilities and future vision of foundation models.
Moderator
Fumihito Ushiyama (SyntheticGestalt KK)
Speakers
Norikazu Saiki (Institute of Science Tokyo)
"Engineering super-complex multicellular tissues powered by single-cell foundation model"
Joel Nicholls (SyntheticGestalt KK)
"10 Billion Compound Pretrained Foundational Model for Drug Discovery"
Junya Yamagishi (Preferred Networks, Inc.)
"Applications of Universal Neural Network Potential in Drug Discovery"
Yoh Terada (Alivexis, Inc.)
"The concept of the next gen. drug discovery AI, using scaled and high-quality synthetic data produced by ModBind simulation"
[Exhibition Booth]
・Booth Number: 25 ,1st floor exhibition hall
・Content: Introduction to the company's molecule-specialized foundation AI model and its case studies
About annual meeting
We are looking forward to your participation.
・Place: Tower Hall Funabori (4-1-1 Funabori, Edogawa-ku, Tokyo)
・Registration: https://cbi-society.org/taikai/taikai25/registration.html
・Deadline: October 30th, -17:00
・Website: https://cbi-society.org/taikai/taikai25/index.html
・CBI: https://cbi-society.org/index.html
About SyntheticGestalt
SyntheticGestalt develops AI technology specialized in molecular information. In 2024 and 2025, we unveiled the world's largest molecule-specific foundation model at NVIDIA GTC (one of the world's largest AI conferences). Our molecular foundation model resolves accuracy challenges faced by conventional molecular AI. We aim to apply this technology across various fields including pharmaceuticals, cosmetics, agrochemicals, and new materials. Our mission is to contribute to the advancement of civilization through AI-driven innovations.
